Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Search Results
7 results
Filters applied: . Clear all
Results are displayed in a computed author sort order.
The Results By Year timeline is not available.
Page 1
Complementary activity of tyrosine kinase inhibitors against secondary kit mutations in imatinib-resistant gastrointestinal stromal tumours.
Br J Cancer. 2019 Mar;120(6):612-620. doi: 10.1038/s41416-019-0389-6. Epub 2019 Feb 22.
Br J Cancer. 2019.
PMID: 30792533
Free PMC article.
CDKN2A/p16 Loss Implicates CDK4 as a Therapeutic Target in Imatinib-Resistant Dermatofibrosarcoma Protuberans.
Eilers G, Czaplinski JT, Mayeda M, Bahri N, Tao D, Zhu M, Hornick JL, Lindeman NI, Sicinska E, Wagner AJ, Fletcher JA, Mariño-Enriquez A.
Eilers G, et al. Among authors: czaplinski jt.
Mol Cancer Ther. 2015 Jun;14(6):1346-53. doi: 10.1158/1535-7163.MCT-14-0793. Epub 2015 Apr 7.
Mol Cancer Ther. 2015.
PMID: 25852058
Free PMC article.
Item in Clipboard
Preclinical activity of selinexor, an inhibitor of XPO1, in sarcoma.
Nakayama R, Zhang YX, Czaplinski JT, Anatone AJ, Sicinska ET, Fletcher JA, Demetri GD, Wagner AJ.
Nakayama R, et al. Among authors: czaplinski jt.
Oncotarget. 2016 Mar 29;7(13):16581-92. doi: 10.18632/oncotarget.7667.
Oncotarget. 2016.
PMID: 26918731
Free PMC article.
Item in Clipboard
Correction: Complementary activity of tyrosine kinase inhibitors against secondary kit mutations in imatinib-resistant gastrointestinal stromal tumours.
Serrano C, Mariño-Enríquez A, Tao DL, Ketzer J, Eilers G, Zhu M, Yu C, Mannan AM, Rubin BP, Demetri GD, Raut CP, Presnell A, McKinley A, Heinrich MC, Czaplinski JT, Sicinska E, Bauer S, George S, Fletcher JA.
Serrano C, et al. Among authors: czaplinski jt.
Br J Cancer. 2019 Jul;121(3):281. doi: 10.1038/s41416-019-0487-5.
Br J Cancer. 2019.
PMID: 31123346
Free PMC article.
Item in Clipboard
Genome-wide functional screening identifies CDC37 as a crucial HSP90-cofactor for KIT oncogenic expression in gastrointestinal stromal tumors.
Mariño-Enríquez A, Ou WB, Cowley G, Luo B, Jonker AH, Mayeda M, Okamoto M, Eilers G, Czaplinski JT, Sicinska E, Wang Y, Taguchi T, Demetri GD, Root DE, Fletcher JA.
Mariño-Enríquez A, et al. Among authors: czaplinski jt.
Oncogene. 2014 Apr 3;33(14):1872-6. doi: 10.1038/onc.2013.127. Epub 2013 Apr 15.
Oncogene. 2014.
PMID: 23584476
Free PMC article.
Item in Clipboard
Antiproliferative effects of CDK4/6 inhibition in CDK4-amplified human liposarcoma in vitro and in vivo.
Zhang YX, Sicinska E, Czaplinski JT, Remillard SP, Moss S, Wang Y, Brain C, Loo A, Snyder EL, Demetri GD, Kim S, Kung AL, Wagner AJ.
Zhang YX, et al. Among authors: czaplinski jt.
Mol Cancer Ther. 2014 Sep;13(9):2184-93. doi: 10.1158/1535-7163.MCT-14-0387. Epub 2014 Jul 15.
Mol Cancer Ther. 2014.
PMID: 25028469
Item in Clipboard
c-Jun promotes cell migration and drives expression of the motility factor ENPP2 in soft tissue sarcomas.
Sioletic S, Czaplinski J, Hu L, Fletcher JA, Fletcher CD, Wagner AJ, Loda M, Demetri GD, Sicinska ET, Snyder EL.
Sioletic S, et al.
J Pathol. 2014 Oct;234(2):190-202. doi: 10.1002/path.4379. Epub 2014 Aug 1.
J Pathol. 2014.
PMID: 24852265
Free PMC article.
Item in Clipboard
Cite
Cite